Mackay Shields LLC has filed its 13F form on October 27, 2025 for Q3 2025 where it was disclosed a total value porftolio of $399 Million distributed in 354 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ishares Gold Trust with a value of $38.2M, Black Rock Municipal 2030 Target Term Trust with a value of $31.9M, Talos Energy Inc. with a value of $29.7M, Blackrock Muniholdings Fund, Inc. with a value of $25.5M, and Gulfport Energy Corp with a value of $23.7M.
Examining the 13F form we can see an decrease of $82.9M in the current position value, from $482M to 399M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$399 Million
Financial Services: $289 Million
Energy: $53.5 Million
ETFs: $43.7 Million
Communication Services: $12.1 Million
Consumer Defensive: $672,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 5.98%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.33%
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.03%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.46%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.4%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.42%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.93%
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.56%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 31.93%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.46%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 15.17%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.26%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.36%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.77%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 50.86%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 9.16%
-
$0
0.0% of portfolio
-
Q3 2025
Added 29.1%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.42%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 11.51%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.01%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 20.44%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.68%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 14.38%
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.6%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.24%
-
$0
0.0% of portfolio
-
Q2 2025
Added 233.06%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.45%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.47%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 6.97%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.19%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 23.19%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 30.3%
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 99.77%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.5%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 40.42%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.48%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.35%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.59%
-
$0
0.0% of portfolio
-
Q2 2025
Added 18.11%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.44%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.18%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.52%